Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 30;18(6):2096375.
doi: 10.1080/21645515.2022.2096375. Epub 2022 Aug 11.

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China

Affiliations

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China

Dong Li et al. Hum Vaccin Immunother. .

Abstract

Background: Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule. Several mumps outbreaks have occurred recently in Fujian. Serological surveillance can assess population immunity to mumps and identify risk factors for mumps.

Methods: We conducted a cross-sectional serosurvey of mumps IgG antibodies in the general population of Fujian Province in 2018 and compare results with a similar study conducted in 2009, when the routine schedule had no MuCV. We analyzed changes in mumps epidemiology after implementation of a one-dose MuCV vaccination strategy.

Results: Mumps seroprevalence was 78.6% (95% CI: 77.4-79.8), and the geometric mean concentration (GMC) of mumps antibodies was 245.8 IU/ml (95% CI:237.3-255.1). MuCV vaccination at 18 months resulted in increased seroprevalence and GMCs. Seroprevalence and GMCs varied by age, gender, and number of doses received. Except for children under 18 months, seroprevalence and GMCs were lowest among 10-15-year-olds. Each year after introduction of the one-dose MuCV vaccination policy, the highest incidence of mumps was among 4-6-year-olds and 9-15-year-olds, gradually shifting to older age groups.

Conclusion: A one-dose mumps-containing vaccine schedule does not provide sustained and stable mumps immunity in Fujian. To reduce the risk of mumps, we recommend supplementary vaccination of children without a history of receiving at least one MuCV dose or who are seronegative at 10-15 years of age.

Keywords: Geometric Mean Concentration (GMC); Mumps; measles-mumps-rubella vaccine (MMR); seroprevalence; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1.
Figure 1.
Age specific mumps seroprevalence in 2009 and 2018. Error bars represent 95% CIs.
Figure 2.
Figure 2.
GMCs by age group in 2009 and 2018. Age specific geometric mean mumps antibody concentrations (GMCs) in 2009 (blue line) and 2018 (red line). Error bars represent 95% CI.
Figure 3.
Figure 3.
Epidemiological characteristics of mumps in Fujian province, 2005–2019.

Similar articles

Cited by

References

    1. Liu Y, Hu Y, Deng X, Wang Z, Lu P, Ma F, Zhou M, Liu P, Min J.. Seroepidemiology of mumps in the general population of Jiangsu province, China after introduction of a one-dose measles-mumps-rubella vaccine. Sci Rep. 2015;5(14660). doi:10.1038/srep14660. - DOI - PMC - PubMed
    1. Su SB, Chang HL, Chen KT. Current status of mumps virus infection: epidemiology, pathogenesis, and vaccine. Int J Mol Sci. 2020;17:1. doi:10.3390/ijerph17051686. - DOI - PMC - PubMed
    1. Cui A, Zhu Z, Hu Y, Deng X, Sun Z, Zhang Y, Mao N, Xu S, Fang X, Gao H, et al. Mumps epidemiology and mumps virus genotypes circulating in mainland China during 2013-2015. Plos One. 2017. doi:10.1371/journal.pone.0169561. - DOI - PMC - PubMed
    1. Cui A, Zhu Z, Chen M, Zheng H, Liu L, Wang Y, Ma Y, Wang C, Fang X, Li P, et al. Epidemiologic and genetic characteristics of mumps viruses isolated in China from 1995 to 2010. Infect Genet Evoln. 2014;21:384–7. doi:10.1016/j.meegid.2013.1012.1005. - DOI - PubMed
    1. Hviid A, Rubin S. Mühlemann K. Mumps. Lancet. 2008;371(9616):932–944. doi:10.1016/S0140-6736(1008)60419-60415. - DOI - PubMed

Substances